![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Irritable Bowel Syndrome |
|
Free Subscription
1 Acta Microbiol Immunol Hung |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Irritable Bowel Syndrome is free of charge.
From Dysbiosis to systemic health: Microbiome modulation as a unified therapeutic
framework.
Acta Microbiol Immunol Hung. 2026 Aug 7:030.2026.03015.
PubMed
Abstract available
Impact of 3-day turmeric supplementation on fasting and postprandial LPS and
chylomicron-related markers in patients with IBS: A randomized crossover trial.
Br J Nutr. 2026 Aug 3:1-28. doi: 10.1017/S0007114526108101.
PubMed
Abstract available
What is new in abdominal pain-related disorders of the gut-brain interaction in
children.
Curr Opin Pediatr. 2026 Aug 6. doi: 10.1097/MOP.0000000000001597.
PubMed
Abstract available
Impact of GLP-1 Analogue Therapy on Gastrointestinal Outcomes in Patients with
Irritable Bowel Syndrome: A Real-World TriNetX Analysis.
Dig Dis Sci. 2026 Aug 8. doi: 10.1007/s10620-026-10171.
PubMed
Abstract available
Saikosaponin D Improves Diarrhea-Predominant Irritable Bowel Syndrome by
Regulating the Brain-Gut Axis: Based on Changes in the Gut HMGB1-TLR4/NF-kappaB
Pathway and Hypothalamic HPA Axis.
Dig Dis Sci. 2026 Aug 6. doi: 10.1007/s10620-026-10165.
PubMed
Abstract available
Randomized Placebo-Controlled Trial of Psyllium Fiber in Functional Abdominal
Pain Disorders in Children.
Dig Dis Sci. 2026 Aug 4. doi: 10.1007/s10620-026-10156.
PubMed
Abstract available
Dietary modulation of transient receptor potential vanilloid 1 as a potential
therapeutic target in irritable bowel syndrome and other disorders of gut-brain
interaction.
Eur J Gastroenterol Hepatol. 2026;38:1110-1111.
PubMed
Gastrointestinal symptoms, faecal short-chain fatty acids and dietary intake in
older adults: the Hordaland Health Study 3.
Eur J Nutr. 2026;65:230.
PubMed
Abstract available
Front Gastroenterol (Lausanne)
A real-world assessment of healthcare resource utilization following IBS-Smart
((R)) and Trio-Smart ((R)) testing in patients with suspected irritable bowel
syndrome.
Front Gastroenterol (Lausanne). 2026;5:1681818.
PubMed
Abstract available
Unveiling the aging-immune axis in irritable bowel syndrome: a multi-omics and
machine learning approach to biomarker discovery and validation.
Front Immunol. 2026;17:1893702.
PubMed
Abstract available
Mapping research trends in irritable bowel syndrome and the gut microbiome: a
cross-database bibliometric analysis.
Front Microbiol. 2026;17:1900159.
PubMed
Abstract available
Gastro Grand Rounds:Managing Complex IBS: A Multidisciplinary, Mechanism-Based
Approach.
Gastroenterology. 2026 Aug 4:S0016-5085(26)07124.
PubMed
Letter in reply: should SNRIs be considered the most effective neuromodulators
for IBS?
Gut. 2026 Aug 5:gutjnl-2026-340150. doi: 10.1136/gutjnl-2026-340150.
PubMed
Faecal proteases and immune signatures drive subtype-specific enteric neuronal
activation in IBS.
Gut. 2026 Aug 4:gutjnl-2025-337949. doi: 10.1136/gutjnl-2025-337949.
PubMed
Abstract available
Cost-of-Illness of Irritable Bowel Syndrome: A Systematic Review.
J Gastroenterol Hepatol. 2026 Jul 31. doi: 10.1111/jgh.70618.
PubMed
Abstract available
Long-term risk of incident psoriasis in patients with irritable bowel syndrome: a
large-scale prospective cohort study.
J Glob Health. 2026;16:04140.
PubMed
Abstract available
Dietary management of gastrointestinal disease: progress over the last decade and
opportunities for the next.
Lancet Gastroenterol Hepatol. 2026;11:738-741.
PubMed
Fecal microbiota profiling in patients with irritable bowel syndrome and small
intestinal bacterial overgrowth.
Medicine (Baltimore). 2026;105:e49955.
PubMed
Abstract available
HIF-1alpha inhibits the TLR4/NF-kappaB signaling pathway and modulates intestinal flora
in diarrhea-predominant irritable bowel syndrome.
PLoS One. 2026;21:e0355467.
PubMed
Abstract available
Abdominal bloating frequency and clinical burden in irritable bowel syndrome
classified using an operationalized Rome V algorithm.
Rev Esp Enferm Dig. 2026 Aug 4. doi: 10.17235/reed.2026.12014/2026.
PubMed
Abstract available
Thank you for your interest in scientific medicine.